Castle Biosciences (CSTL) Short-term Investments (2022 - 2026)

Castle Biosciences (CSTL) has 5 years of Short-term Investments data on file, last reported at $197.9 million in Q1 2026.

• Quarterly Short-term Investments rose 6.7% year-over-year to $197.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $197.9 million (up 6.7% YoY) and the FY2025 annual result came in at $182.8 million, up 5.39% from the prior year.
• Short-term Investments rose to $197.9 million in Q1 2026 per CSTL's latest filing, from $182.8 million in the prior quarter.
• The five-year high for Short-term Investments was $202.0 million in Q3 2025, with the low at $117.2 million in Q1 2023.
• Average Short-term Investments over 5 years is $163.2 million, with a median of $173.4 million recorded in 2024.
• Year-over-year, Short-term Investments grew 5.08% in 2023 and jumped 34.35% in 2024.
• Castle Biosciences' Short-term Investments stood at $135.7 million in 2022, then rose by 6.32% to $144.3 million in 2023, then grew by 20.22% to $173.4 million in 2024, then climbed by 5.39% to $182.8 million in 2025, then increased by 8.29% to $197.9 million in 2026.
• Business Quant data shows CSTL's Short-term Investments at $197.9 million in Q1 2026, $182.8 million in Q4 2025, and $202.0 million in Q3 2025.